首页> 美国卫生研究院文献>Journal of Clinical Neurology (Seoul Korea) >Life-Threatening Anaphylactoid Reaction in an Acute Ischemic Stroke Patient With Intravenous rt-PA Thrombolysis Followed by Successful Intra-Arterial Thrombolysis
【2h】

Life-Threatening Anaphylactoid Reaction in an Acute Ischemic Stroke Patient With Intravenous rt-PA Thrombolysis Followed by Successful Intra-Arterial Thrombolysis

机译:急性rt-PA静脉溶栓急性缺血性卒中患者危及生命的类过敏反应随后成功进行动脉溶栓

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An anaphylactoid reaction to recombinant tissue plasminogen activator (rt-PA) is an uncommon but fatal complication. A 39-year-old man was admitted within 1 hour of the onset of a right hemispheric stroke. He was not taking any specific medication, including angiotensin-converting enzyme (ACE) inhibitors. A systemic anaphylactoid reaction developed immediately after rt-PA infusion. However, the symptoms were improved after treatment with a steroid and antihistamine. Subsequent intra-arterial thrombolytic therapy resulted in complete recanalization and clinical improvement. To our knowledge, this is the first report of a life-threatening anaphylactoid reaction after rt-PA treatment followed by successful intra-arterial thrombolytic therapy in a patient who had not taken an ACE inhibitor.
机译:对重组组织纤溶酶原激活物(rt-PA)的类过敏反应是一种罕见的致命并发症。一名右脑半球发作后1小时内收治了一名39岁男子。他没有服用任何特定药物,包括血管紧张素转换酶(ACE)抑制剂。 rt-PA输注后立即发生全身性类过敏反应。但是,类固醇和抗组胺药治疗后症状得到改善。随后的动脉内溶栓治疗导致完全的再通和临床改善。据我们所知,这是第一例关于在未接受ACE抑制剂的患者中进行rt-PA治疗后,继之以成功的动脉内溶栓治疗的危及生命的类过敏反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号